Literature DB >> 27508951

Fourfold increase in prevalence of gestational diabetes mellitus after adoption of the new International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria.

Evelyn A Huhn1, Nadine Massaro2, Simone Streckeisen3, Gwendolin Manegold-Brauer4, Andreas Schoetzau4, Sven M Schulzke5, Bettina Winzeler6, Irene Hoesli4, Olav Lapaire4.   

Abstract

BACKGROUND: The aim was to evaluate the influence of the new International Association of Diabetes and Pregnancy Study Groups (IADPSG) guidelines for screening of gestational diabetes mellitus (GDM) on GDM prevalence in a cohort from a Swiss tertiary hospital.
METHODS: This was a retrospective cohort study involving all pregnant women who were screened for GDM between 24 and 28 weeks of gestation. From 2008 until 2010 (period 1), a two-step approach with 1-h 50 g glucose challenge test (GCT) was used, followed by fasting, 1- and 2-h glucose measurements after a 75 g oral glucose tolerance test (OGTT) in case of a positive GCT. From 2010 until 2013 (period 2), all pregnant women were tested with a one-step 75 g OGTT according to new IADPSG guidelines. In both periods, women with risk factors could be screened directly with a 75 g OGTT in early pregnancy.
RESULTS: Overall, 647 women were eligible for the study in period 1 and 720 in period 2. The introduction of the IADPSG criteria resulted in an absolute increase of GDM prevalence of 8.5% (3.3% in period 1 to 11.8% in period 2).
CONCLUSIONS: The adoption of the IADPSG criteria resulted in a considerable increase in GDM diagnosis in our Swiss cohort. Further studies are needed to investigate if the screening is cost effective and if treatment of our additionally diagnosed GDM mothers might improve short-term as well as long-term outcome.

Entities:  

Keywords:  Gestational diabetes mellitus; IADPSG criteria; oral glucose tolerance test; pregnancy; prevalence; screening

Mesh:

Year:  2017        PMID: 27508951     DOI: 10.1515/jpm-2016-0099

Source DB:  PubMed          Journal:  J Perinat Med        ISSN: 0300-5577            Impact factor:   1.901


  14 in total

Review 1.  The role of neutrophil activation in determining the outcome of pregnancy and modulation by hormones and/or cytokines.

Authors:  S Hahn; P Hasler; L Vokalova; S V van Breda; O Lapaire; N G Than; I Hoesli; S W Rossi
Journal:  Clin Exp Immunol       Date:  2019-03-13       Impact factor: 4.330

Review 2.  Gestational diabetes mellitus: an updated overview.

Authors:  E Chiefari; B Arcidiacono; D Foti; A Brunetti
Journal:  J Endocrinol Invest       Date:  2017-03-10       Impact factor: 4.256

3.  Resolving the Gestational Diabetes Diagnosis Conundrum: The Need for a Randomized Controlled Trial of Treatment.

Authors:  Rudolf W Bilous; Paul B Jacklin; Michael J Maresh; David A Sacks
Journal:  Diabetes Care       Date:  2021-04       Impact factor: 17.152

4.  Screening of gestational diabetes mellitus in early pregnancy by oral glucose tolerance test and glycosylated fibronectin: study protocol for an international, prospective, multicentre cohort trial.

Authors:  E A Huhn; T Fischer; C S Göbl; M Todesco Bernasconi; M Kreft; M Kunze; A Schoetzau; E Dölzlmüller; W Eppel; P Husslein; N Ochsenbein-Koelble; R Zimmermann; E Bäz; H Prömpeler; E Bruder; S Hahn; I Hoesli
Journal:  BMJ Open       Date:  2016-10-12       Impact factor: 2.692

5.  Comparison of glyburide and insulin in the management of gestational diabetes: A meta-analysis.

Authors:  Rongjing Song; Ling Chen; Yue Chen; Xia Si; Yi Liu; Yue Liu; David M Irwin; Wanyu Feng
Journal:  PLoS One       Date:  2017-08-03       Impact factor: 3.240

6.  Gestational Diabetes Mellitus Is Associated with Altered Neutrophil Activity.

Authors:  Maria Stoikou; Franco Grimolizzi; Stavros Giaglis; Günther Schäfer; Shane Vontelin van Breda; Irene Mathilde Hoesli; Olav Lapaire; Evelyn A Huhn; Paul Hasler; Simona W Rossi; Sinuhe Hahn
Journal:  Front Immunol       Date:  2017-06-14       Impact factor: 7.561

Review 7.  The Emerging Role of Biomarkers in the Diagnosis of Gestational Diabetes Mellitus.

Authors:  Natassia Rodrigo; Sarah J Glastras
Journal:  J Clin Med       Date:  2018-05-23       Impact factor: 4.241

8.  Follow-up study of neurodevelopment in 2-year-old infants who had suffered from neonatal hypoglycemia.

Authors:  Lin-Xia Qiao; Jian Wang; Ju-Hua Yan; Su-Xiang Xu; Hua Wang; Wen-Ying Zhu; Hai-Yan Zhang; Jie Li; Xing Feng
Journal:  BMC Pediatr       Date:  2019-04-25       Impact factor: 2.125

9.  MicroRNA-351 eases insulin resistance and liver gluconeogenesis via the PI3K/AKT pathway by inhibiting FLOT2 in mice of gestational diabetes mellitus.

Authors:  Shu-Hong Chen; Xiao-Nan Liu; Yan Peng
Journal:  J Cell Mol Med       Date:  2019-07-09       Impact factor: 5.310

10.  Estimated impact of introduction of new diagnostic criteria for gestational diabetes mellitus.

Authors:  Leon de Wit; Anna B Zijlmans; Doortje Rademaker; Christiana A Naaktgeboren; J Hans DeVries; Arie Franx; Rebecca C Painter; Bas B van Rijn
Journal:  World J Diabetes       Date:  2021-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.